Sign in
4

Changes in Ownership

Hims & Hers Health, Inc. Filed Acc 0001773751-25-000280

Chief Executive Officer sold 175,661 shares at an average $45.06 ($7,914,735)

  • Chief Executive Officer acquired 125,335 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dudum Andrew Chief Executive Officer 2025-08-18 Sale 10b5-1 −47,534 $45.05 $2,141,492 142,592 I: show line 1 in the form
Dudum Andrew Chief Executive Officer 2025-08-18 Sale 10b5-1 −2,792 $44.97 $125,542 89,521 D: show line 2 in the form
Dudum Andrew Chief Executive Officer 2025-08-18 Option exercise 10b5-1 +17,001 $2.43 $41,312 106,522 D: show line 3 in the form
Dudum Andrew Chief Executive Officer 2025-08-18 Sale 10b5-1 −17,001 $45.14 $767,379 89,521 D: show line 4 in the form
Dudum Andrew Chief Executive Officer 2025-08-18 Option exercise 10b5-1 +108,334 $2.43 $263,252 197,855 D: show line 5 in the form
Dudum Andrew Chief Executive Officer 2025-08-18 Sale 10b5-1 −41,667 $45.11 $1,879,644 156,188 D: show line 6 in the form
Dudum Andrew Chief Executive Officer 2025-08-18 Sale 10b5-1 −50,000 $45.04 $2,251,980 106,188 D: show line 7 in the form
Dudum Andrew Chief Executive Officer 2025-08-18 Sale 10b5-1 −16,667 $44.92 $748,697 89,521 D: show line 8 in the form
Open-market sales · 175,661 sh · avg $45.06 · $7,914,735

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dudum Andrew Chief Executive Officer 2025-08-18 Option exercise · Stock Option (right to buy) 10b5-1 −17,001 51,007 D: show line 9 in the form
Dudum Andrew Chief Executive Officer 2025-08-18 Option exercise · Stock Option (right to buy) 10b5-1 −108,334 648,063 D: show line 10 in the form
Loading xslF345X05/wk-form4_1755720875.xml…